TKI258 for Metastatic Inflammatory Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Dovitinib
Sponsor: M.D. Anderson Cancer Center
Collaborators: Novartis